UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Treatment evolution after COPD diagnosis in the UK primary care setting

PloS one, 2014-09, Vol.9 (9), p.e105296-e105296

2014

Link zum Volltext

Verfügbarkeit prüfen

Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis

BMC infectious diseases, 2019-05, Vol.19 (1), p.484-484, Article 484

2019

Link zum Volltext

Verfügbarkeit prüfen

COPD management costs according to the frequency of COPD exacerbations in UK primary care

International journal of chronic obstructive pulmonary disease, 2014-01, Vol.9 (default), p.65-73

2014

Link zum Volltext

Verfügbarkeit prüfen

A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population

Infectious diseases and therapy, 2018-06, Vol.7 (2), p.183-195

2018

Link zum Volltext

Verfügbarkeit prüfen

"It made me more confident that I have it under control": Patient and provider perspectives on moving to a two-drug ART regimen in the United States and Spain

PloS one, 2020-05, Vol.15 (5), p.e0232473-e0232473

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis

BMC infectious diseases, 2021-02, Vol.21 (1), p.222-222, Article 222

2021

Link zum Volltext

Verfügbarkeit prüfen

Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset

Respiratory medicine, 2017-01, Vol.122, p.1-11

2017

Link zum Volltext

Verfügbarkeit prüfen

Systematic Review of Humanistic and Economic Burden of Symptomatic Chronic Obstructive Pulmonary Disease

PharmacoEconomics, 2015-05, Vol.33 (5), p.467-488

2015

Link zum Volltext

Verfügbarkeit prüfen

Can Assessment of Disease Burden Prior to Changes in Initial COPD Maintenance Treatment Provide Insight into Remaining Unmet Needs? A Retrospective Database Study in UK Primary Care

Chronic obstructive pulmonary disease, 2017-01, Vol.14 (1), p.80-85

2017

Link zum Volltext

Verfügbarkeit prüfen

A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD

Pulmonary therapy, 2017-12, Vol.3 (2), p.297-316

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.2495-2517

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of laboratory- and field-based exercise tests for COPD: a systematic review

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.625-643

2015

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis

BMC infectious diseases, 2021-04, Vol.21 (1), p.340-340, Article 340

2021

Link zum Volltext

Verfügbarkeit prüfen

Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis

Respiratory research, 2017-05, Vol.18 (1), p.86-86, Article 86

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.1863-1881

2015

Link zum Volltext

Verfügbarkeit prüfen

The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study

NPJ primary care respiratory medicine, 2016-06, Vol.26 (1), p.16031-16031, Article 16031

2016

Link zum Volltext

Verfügbarkeit prüfen

Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients

Cost effectiveness and resource allocation, 2019-12, Vol.17 (1), p.26-26, Article 26

2019

Link zum Volltext

Verfügbarkeit prüfen

Implications of chronic obstructive pulmonary disease (COPD) on patients’ health status: A western view

Respiratory medicine, 2007-03, Vol.101 (3), p.661-669

2007

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Scheduled Maintenance Treatment with Infliximab for Pediatric Crohn's Disease

Value in health, 2010-03, Vol.13 (2), p.188-195

2010

Link zum Volltext

Verfügbarkeit prüfen

Estimating the effect of nasal steroid treatment on repeat polypectomies: survival time analysis using the General Practice Research Database

Rhinology, 2011-06, Vol.49 (2), p.190-194

2011

Link zum Volltext

Verfügbarkeit prüfen

Relationship Between FEV1 and Patient-Reported Outcomes Changes: Results of a Meta-Analysis of Randomized Trials in Stable COPD

Chronic obstructive pulmonary diseases, 2016-03, Vol.3 (2), p.519-538

2016

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of infliximab for the treatment of active and progressive psoriatic arthritis

Value in health, 2011, Vol.14 (1), p.15-23

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparative efficacy and safety and dolutegravir and lamivudine in treatment naive HIV patients

AIDS (London), 2019-09, Vol.33 (11), p.1739-1749

2019

Link zum Volltext

Verfügbarkeit prüfen

Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

The Lancet infectious diseases, 2019-03, Vol.19 (3), p.253-264

2019

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, determinants, and impact of suboptimal adherence to HIV medication in 25 countries

Preventive medicine, 2020-10, Vol.139, p.106182-106182, Article 106182

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(57)
Dissertationen
(1)

Sprache

Englisch
(58)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(35)
Humans
(31)
Female
(21)
Male
(21)
Aged
(15)
Middle Aged
(15)
Respiratory System
(15)
Patients
(14)
Chronic Obstructive Pulmonary Disease
(13)
Drug Therapy
(11)
Lung Diseases, Obstructive
(11)
Treatment Outcome
(11)
Cost-Benefit Analysis
(10)
Health Care Sciences & Services
(10)
Hiv
(10)
Pulmonary Disease, Chronic Obstructive - Diagnosis
(10)
Clinical Trials
(9)
Copd
(9)
Pulmonary Disease, Chronic Obstructive - Drug Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment evolution after COPD diagnosis in the UK primary care setting

Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis

COPD management costs according to the frequency of COPD exacerbations in UK primary care

A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population

"It made me more confident that I have it under control": Patient and provider perspectives on moving to a two-drug ART regimen in the United States and Spain

Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis

Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset

Systematic Review of Humanistic and Economic Burden of Symptomatic Chronic Obstructive Pulmonary Disease

Can Assessment of Disease Burden Prior to Changes in Initial COPD Maintenance Treatment Provide Insight into Remaining Unmet Needs? A Retrospective Database Study in UK Primary Care

A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD

Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis

Comparison of laboratory- and field-based exercise tests for COPD: a systematic review

Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis

Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis

Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis

The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study

Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients

Implications of chronic obstructive pulmonary disease (COPD) on patients’ health status: A western view

Cost-Effectiveness of Scheduled Maintenance Treatment with Infliximab for Pediatric Crohn's Disease

Estimating the effect of nasal steroid treatment on repeat polypectomies: survival time analysis using the General Practice Research Database

Relationship Between FEV1 and Patient-Reported Outcomes Changes: Results of a Meta-Analysis of Randomized Trials in Stable COPD

Cost-effectiveness of infliximab for the treatment of active and progressive psoriatic arthritis

Comparative efficacy and safety and dolutegravir and lamivudine in treatment naive HIV patients

Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

Prevalence, determinants, and impact of suboptimal adherence to HIV medication in 25 countries

Suchergebnisse filtern